Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 406,758
  • Shares Outstanding, K 184,890
  • Annual Sales, $ 186,800 K
  • Annual Income, $ -37,490 K
  • 60-Month Beta 1.20
  • Price/Sales 2.61
  • Price/Cash Flow N/A
  • Price/Book 8.15
Trade CERS with:

Options Overview Details

View History
  • Implied Volatility 89.96% ( -10.74%)
  • Historical Volatility 75.08%
  • IV Percentile 68%
  • IV Rank 18.60%
  • IV High 422.79% on 10/06/23
  • IV Low 13.90% on 07/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 38
  • Volume Avg (30-Day) 118
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 4,678
  • Open Int (30-Day) 4,958

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.64 +41.03%
on 07/05/24
2.43 -4.53%
on 07/17/24
+0.63 (+37.28%)
since 06/21/24
3-Month
1.61 +44.10%
on 04/25/24
2.43 -4.53%
on 07/17/24
+0.63 (+37.28%)
since 04/22/24
52-Week
1.21 +92.53%
on 10/09/23
3.08 -24.68%
on 07/31/23
-0.56 (-19.44%)
since 07/21/23

Most Recent Stories

More News
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 2.32 (+5.45%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 2.32 (+5.45%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

^BTCUSD : 67,500.45 (-0.75%)
^BTCUSDT : 67,455.80 (-0.53%)
TSLA : 251.51 (+5.15%)
ARKB : 68.31 (+1.50%)
CERS : 2.32 (+5.45%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 3.01 (+1.35%)
CERS : 2.32 (+5.45%)
TSHA : 2.18 (+1.87%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 2.32 (+5.45%)
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 2.32 (+5.45%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

COIN : 265.15 (+2.86%)
RKLB : 5.34 (+2.69%)
CERS : 2.32 (+5.45%)
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 2.32 (+5.45%)
Cerus Corporation Announces First Quarter 2023 Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2023.

CERS : 2.32 (+5.45%)
Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on Thursday, May 4, 2023, after the close of the stock market. The Company will host a conference...

CERS : 2.32 (+5.45%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 2.51
2nd Resistance Point 2.41
1st Resistance Point 2.37
Last Price 2.32
1st Support Level 2.23
2nd Support Level 2.13
3rd Support Level 2.09

See More

52-Week High 3.08
Fibonacci 61.8% 2.36
Last Price 2.32
Fibonacci 50% 2.14
Fibonacci 38.2% 1.92
52-Week Low 1.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar